Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial

Lara Fairall, Max O Bachmann, Carl Lombard, Venessa Timmerman, Kerry Uebel, Merrick Zwarenstein, Andrew Boulle, Daniella Georgeu, Christopher J Colvin, Simon Lewin, Gill Faris, Ruth Cornick, Beverly Draper, Mvula Tshabalala, Eduan Kotze, Cloete van Vuuren, Dewald Steyn, Ronald Chapman, Eric Bateman, Lara Fairall, Max O Bachmann, Carl Lombard, Venessa Timmerman, Kerry Uebel, Merrick Zwarenstein, Andrew Boulle, Daniella Georgeu, Christopher J Colvin, Simon Lewin, Gill Faris, Ruth Cornick, Beverly Draper, Mvula Tshabalala, Eduan Kotze, Cloete van Vuuren, Dewald Steyn, Ronald Chapman, Eric Bateman

Abstract

Background: Robust evidence of the effectiveness of task shifting of antiretroviral therapy (ART) from doctors to other health workers is scarce. We aimed to assess the effects on mortality, viral suppression, and other health outcomes and quality indicators of the Streamlining Tasks and Roles to Expand Treatment and Care for HIV (STRETCH) programme, which provides educational outreach training of nurses to initiate and represcribe ART, and to decentralise care.

Methods: We undertook a pragmatic, parallel, cluster-randomised trial in South Africa between Jan 28, 2008, and June 30, 2010. We randomly assigned 31 primary-care ART clinics to implement the STRETCH programme (intervention group) or to continue with standard care (control group). The ratio of randomisation depended on how many clinics were in each of nine strata. Two cohorts were enrolled: eligible patients in cohort 1 were adults (aged ≥16 years) with CD4 counts of 350 cells per μL or less who were not receiving ART; those in cohort 2 were adults who had already received ART for at least 6 months and were being treated at enrolment. The primary outcome in cohort 1 was time to death (superiority analysis). The primary outcome in cohort 2 was the proportion with undetectable viral loads (<400 copies per mL) 12 months after enrolment (equivalence analysis, prespecified difference <6%). Patients and clinicians could not be masked to group assignment. The interim analysis was blind, but data analysts were not masked after the database was locked for final analysis. Analyses were done by intention to treat. This trial is registered, number ISRCTN46836853.

Findings: 5390 patients in cohort 1 and 3029 in cohort 2 were in the intervention group, and 3862 in cohort 1 and 3202 in cohort 2 were in the control group. Median follow-up was 16·3 months (IQR 12·2-18·0) in cohort 1 and 18·0 months (18·0-18·0) in cohort 2. In cohort 1, 997 (20%) of 4943 patients analysed in the intervention group and 747 (19%) of 3862 in the control group with known vital status at the end of the trial had died. Time to death did not differ (hazard ratio [HR] 0·94, 95% CI 0·76-1·15). In a preplanned subgroup analysis of patients with baseline CD4 counts of 201-350 cells per μL, mortality was slightly lower in the intervention group than in the control group (0·73, 0·54-1.00; p=0·052), but it did not differ between groups in patients with baseline CD4 of 200 cells per μL or less (0·94, 0·76-1·15; p=0·577). In cohort 2, viral load suppression 12 months after enrolment was equivalent in intervention (2156 [71%] of 3029 patients) and control groups (2230 [70%] of 3202; risk difference 1·1%, 95% CI -2·4 to 4·6).

Interpretation: Expansion of primary-care nurses' roles to include ART initiation and represcription can be done safely, and improve health outcomes and quality of care, but might not reduce time to ART or mortality.

Funding: UK Medical Research Council, Development Cooperation Ireland, and Canadian International Development Agency.

Copyright © 2012 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
Trial profile for cohort 1 ART=antiretroviral therapy. *105 of these patients died after the trial started. †119 of these patients died after the trial started.
Figure 2
Figure 2
Trial profile for cohort 2 ART=antiretroviral therapy. *22 of these patients died after the trial started. †22 of these patients died after the trial started. ‡After 12 months of follow-up, patients had been recorded as withdrawn or relocated, or they had had no clinic visit or laboratory test in the previous 6 months, and we had no documentation of death.
Figure 3
Figure 3
Kaplan-Meier curves of time to death (A) Cohort 1. (B) CD4 subgroups of cohort 1. (C) Cohort 2.

References

    1. WHO Task shifting: global recommendations and guidelines. 2008. (accessed June 25, 2012).
    1. Callaghan M, Ford N, Schneider H. A systematic review of task-shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8.
    1. Jaffar S, Amuron B, Foster S. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009;374:2080–2089.
    1. Sanne I, Orrell C, Fox MP. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet. 2010;376:33–40.
    1. Fairall LR, Bachmann MO, Louwagie G. Effectiveness of antiretroviral treatment in a South African program: cohort study. Arch Intern Med. 2008;168:86–93.
    1. Ingle S, May M, Uebel K. Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS. 2010;24:2717–2725.
    1. Fairall L, Zwarenstein M, Bateman ED. Educational outreach to nurses improves tuberculosis case detection and primary care of respiratory illness: a pragmatic cluster randomised controlled trial. BMJ. 2005;331:750–754.
    1. Zwarenstein M, Fairall LR, Lombard C. Outreach education integrates HIV/AIDS/ART and tuberculosis care in South African primary care clinics: a pragmatic cluster randomized trial. BMJ. 2011;342:d2022.
    1. Bachmann MO, Fairall LR, Lombard C. Effect on tuberculosis outcomes of educational outreach to South African clinics during two randomised trials. Int J Tuberculosis Lung Dis. 2010;14:311–317.
    1. Fairall LR, Bachmann MO, Zwarenstein MF. Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocol. Trials. 2008;9:21.
    1. Medical Research Council Cluster Randomised Trials: methodological and ethical considerations. Nov 11, 2002. (accessed Aug 10, 2011).
    1. Haines A, Ashcroft R, Coggon D. Personal information in medical research. Oct 9, 2000. (accessed Aug 10, 2011).
    1. South African National Department of Health National antiretroviral treatment guidelines: 1st edn. 2004. (accessed June 25, 2012).
    1. Knowledge Translation Unit. University of Cape Town Lung Institute . Practical Approach to Lung Health and HIV/AIDS (PALSA PLUS) Guidelines. Knowledge Translation Unit; Cape Town: 2006.
    1. Uebel KU, Fairall LR, van Rensburg HCJ. Task shifting and integration of HIV care into primary care in South Africa: the development and content of the streamlining tasks and roles to expand treatment and care of HIV (STRETCH) intervention. Implement Sci. 2011;6:86.
    1. Statistics South Africa . Mortality and causes of death in South Africa, 1997–2003: findings from death notification. Statistics South Africa; Pretoria: 2005.
    1. Donner A. Approaches to sample size estimation in the design of clinical trials—a review. Stat Med 198; 3: 199–214.
    1. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323:1123–1124.
    1. Colvin CJ, Fairall L, Lewin S. Expanding access to ART in South Africa: the role of nurse initiated treatment. S Afr Med J. 2010;100:210–211.
    1. Bateman C. Free State ARV crisis—central government blamed. S Afr Med J. 2009;99:284–287.
    1. Boseley S. Crisis looms as Global Fund forced to cut back on AIDS, malaria and TB grants. Nov 23, 2011. (accessed April 11, 2012).
    1. Selke HM, Kimaiyo S, Sidle JE. Task-shifting of antiretroviral delivery from health care workers to persons with HIV/AIDS: clinical outcomes of a community-based program in Kenya. J Acquir Immune Defic Syndr. 2010;55:483–490.
    1. Chang LW, Kagaayi J, Nakigozi G. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomised trial. PLoS One. 2010;5:e10923.
    1. Cornell M, Grimsrud A, Fairall L. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007. AIDS. 2010;24:2263–2270.
    1. Schull MJ, Cornick R, Thompson S. From PALSA PLUS to PALM PLUS: adapting and developing a South African guideline and training intervention to better integrate HIV/AIDS care with primary care in rural health centers in Malawi. Implement Sci. 2011;6:82.
    1. Schull MJ, Banda H, Kathyola D. Strengthening health human resources and improving clinical outcomes through an integrated guideline and educational outreach in resource-poor settings: a cluster-randomized trial. Trials. 2010;11:118.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever